Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

BMP signaling prevents hair growth by stopping stem cell activation.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Abrocitinib may effectively treat stubborn alopecia universalis.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.